Ivantis, Inc., a leading innovator in the ophthalmic medical device industry, is headquartered in the United States. Founded in 2010, the company has made significant strides in developing advanced solutions for glaucoma treatment, focusing on minimally invasive surgical techniques. Ivantis is renowned for its flagship product, the Hydrus Microstent, which uniquely combines the benefits of micro-invasive surgery with the effectiveness of traditional glaucoma treatments. This device has positioned Ivantis as a key player in the ophthalmic market, addressing the needs of both patients and healthcare providers. With a commitment to improving patient outcomes, Ivantis continues to expand its operational reach, contributing to advancements in eye care and solidifying its reputation as a trusted name in the industry.
We don't have data for Ivantis, Inc., but we can show you information about their parent organization instead.
View parent company